H1 (Interim)
BDRX — H1 2026 Financial Report Analysis
Biodexa's first-half net loss halved to £1.84m only because a falling share price shrank a warrant liability; operating cash burn rose 40% to £4.61m, cash fell to £3.23m and the company says it needs new funding in Q4 2026.